Defining and Estimating the Cure Fraction Bias in Survival Modelling of Novel Immuno-Oncology Therapy Agents in Small-Cell Lung Cancer
May 1, 2018, 00:00 AM
10.1016/j.jval.2018.04.1435
https://www.valueinhealthjournal.com/article/S1098-3015(18)31741-8/fulltext
Section Title :
Section Order :
682
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31741-8&doi=10.1016/j.jval.2018.04.1435